Detalles de la búsqueda
1.
Extended therapy with letrozole as adjuvant treatment of postmenopausal patients with early-stage breast cancer: a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1458-1467, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34543613
2.
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
Int J Med Sci
; 18(10): 2245-2250, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33859534
3.
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting.
Int J Cancer
; 146(7): 1917-1929, 2020 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31330065
4.
Dose-dense adjuvant chemotherapy in early breast cancer patients: 15-year results of the Phase 3 Mammella InterGruppo (MIG)-1 study.
Br J Cancer
; 122(11): 1611-1617, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32231293
5.
Endocrine therapy for hormone receptor-positive, HER2-negative metastatic breast cancer: extending endocrine sensitivity.
Future Oncol
; 16(5): 129-145, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31849236
6.
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience.
J Cell Physiol
; 234(6): 7708-7717, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30536609
7.
Eribulin in the treatment of advanced breast cancer: real-world scenario from 39 Italian centers - ESEMPiO study.
Future Oncol
; 15(1): 33-44, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30411979
8.
Neoadjuvant chemotherapy in triple-negative breast cancer: A multicentric retrospective observational study in real-life setting.
J Cell Physiol
; 233(3): 2313-2323, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28710865
9.
A Real-World Multicentre Retrospective Study of Paclitaxel-Bevacizumab and Maintenance Therapy as First-Line for HER2-Negative Metastatic Breast Cancer.
J Cell Physiol
; 232(6): 1571-1578, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-27861874
10.
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
Oncologist
; 22(6): 648-654, 2017 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432226
11.
Body Mass Index and Treatment Outcomes in Metastatic Breast Cancer Patients Treated With Eribulin.
J Cell Physiol
; 231(5): 986-91, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26449308
12.
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trial.
Breast Cancer Res Treat
; 155(1): 117-26, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26661403
13.
Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
JAMA
; 314(24): 2632-40, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26720025
14.
Outcomes of HER2-positive early breast cancer patients in the pre-trastuzumab and trastuzumab eras: a real-world multicenter observational analysis. The RETROHER study.
Breast Cancer Res Treat
; 147(3): 599-607, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25234842
15.
Prognostic and clinical impact of the endocrine resistance/sensitivity classification according to international consensus guidelines for advanced breast cancer: an individual patient-level analysis from the Mammella InterGruppo (MIG) and Gruppo Italiano Mammella (GIM) studies.
EClinicalMedicine
; 59: 101931, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-37256095
16.
Clinical Outcomes of HER2-Negative Metastatic Breast Cancer Patients in Italy in the Last Decade: Results of the GIM 13-AMBRA Study.
Cancers (Basel)
; 16(1)2023 Dec 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-38201545
17.
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study.
Front Oncol
; 13: 1152123, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37260975
18.
Ribociclib Plus Letrozole in Italian Male Patients with Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: Case Studies of Phase 3b CompLEEment-1 Trial.
Breast Cancer (Dove Med Press)
; 14: 351-362, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36267663
19.
Circulating Cytokines in Metastatic Breast Cancer Patients Select Different Prognostic Groups and Patients Who Might Benefit from Treatment beyond Progression.
Vaccines (Basel)
; 10(1)2022 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35062739
20.
Long-Term Outcomes With Pharmacological Ovarian Suppression During Chemotherapy in Premenopausal Early Breast Cancer Patients.
J Natl Cancer Inst
; 114(3): 400-408, 2022 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34850043